Sodium Sulfacetamide, Sulfur NDC 44523-550

NDC codes

FDA NDC Directory

Product NDC (as listed)44523-550Labeler and product segments. Claims need a package NDC.

Product NDC at billing width44523-0550Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
44523-550-08	44523055008	227 g in 1 BOTTLE, PLASTIC (44523-550-08)Marketed from Sep 15, 2011

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Sulfacetamide, Sulfur
Generic name (nonproprietary): sulfacetamide sodium, sulfur
Active ingredients: Sulfacetamide sodium — 100 mg/gSulfur — 20 mg/g
Dosage form: Emulsion
Route: Topical
Labeler: BioComp Pharma, Inc.
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Sep 15, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Sulfonamides (Chemical structure)
Identifiers: Product ID 44523-550_f798f8d7-639f-2a12-e053-6294a90a00fbSPL ID f798f8d7-639f-2a12-e053-6294a90a00fbSPL set ID 99e52390-478e-49ed-87de-aa794379bfebRxCUI 1000895UNII 4NRT660KJQ, 70FD1KFU70UPC 0344523550087
Pharmacologic class: Sulfonamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N444523055008 followed by a unit qualifier and the quantity

Package 44523-0550-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 24, 2023.

Indications (excerpt from the label)

INDICATIONS: This product is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)